Sorich Megan M, Cherian Jeffery J, McElroy Mark J, Banerjee Samik, Jones Lynne C, Minniti Caterina P, Mont Michael A
Rowan University School of Osteopathic Medicine, Stratford, New Jersey.
Center for Joint Preservation and Replacement, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.
J Long Term Eff Med Implants. 2015;25(4):253-68. doi: 10.1615/jlongtermeffmedimplants.2015012529.
Osteonecrosis of the hip can lead to advanced arthritis in typically young patients. Hematologic disorders comprise one group of potential causes. These include sickle cell anemia, hemophilia, aplastic anemia, thalassemia, and acute lymphoblastic leukemia. Depending on the stage of disease, treatment options include non-operative management, joint-preserving procedures (percutaneous drilling, core decompression, and vascularized or non-vascularized bone grafting), and joint arthroplasty (resurfacing arthroplasty and THA). Numerous small studies have investigated the efficacy of these options in patients who have specific hematologic disorders. Therefore, this report provides a comprehensive review of the osteonecrosis treatment options and results across the spectrum of patients who have various hematologic disorders.
髋关节骨坏死通常会在年轻患者中导致晚期关节炎。血液系统疾病是一组潜在病因。这些疾病包括镰状细胞贫血、血友病、再生障碍性贫血、地中海贫血和急性淋巴细胞白血病。根据疾病阶段,治疗选择包括非手术治疗、保关节手术(经皮钻孔、髓芯减压以及带血管或不带血管的骨移植)和关节置换术(表面置换术和全髋关节置换术)。许多小型研究调查了这些治疗方法对患有特定血液系统疾病患者的疗效。因此,本报告全面综述了患有各种血液系统疾病患者的骨坏死治疗选择及结果。